Research study Program year 2022 Source: CMS Open Payments

Phase II study of BI456906 patients with T2DM Obes

Research payments

$1,878,693

32 payments

Through program year 2022, $1,878,693 in research payments was reported against Phase II study of BI456906 patients with T2DM Obes, across 32 payments, paid by Boehringer Ingelheim Pharmaceuticals, Inc..

Paid by
Boehringer Ingelheim Pharmaceuticals, Inc.
ClinicalTrials.gov
No trial number was reported for this study

By program year

3 rows
Year Kind Amount Payments
2022 Research $223,470 7
2021 Research $1,591,844 14
2020 Research $63,379 11

Breakdown

Who paid Research payments · program years 2020–2022
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $1,878,693 32 payments
Who received the money Research payments · program years 2020–2022
  1. Indago Research and Health Center Organisation paid for research $658,709 7 payments
  2. Valley Clinical Trials Organisation paid for research $456,232 4 payments
  3. Lucas Research INC Organisation paid for research $367,122 3 payments
  4. San Marcus Research Clinic INC Organisation paid for research $311,151 2 payments
  5. Sandhill Research LLC Organisation paid for research $26,033 1 payment
  6. Pmg Research INC Organisation paid for research $21,385 5 payments
  7. Lucas Research Organisation paid for research $14,235 2 payments
  8. San Marcus Research Clinic Organisation paid for research $14,074 1 payment
  9. Dupage Medical Group Family Practice Organisation paid for research $5,555 3 payments
  10. Meridien Research Organisation paid for research $3,580 3 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record